The Interleukin-6 inflammation pathway from cholesterol to aging - Role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases

Immunity and Ageing

Volumn 4, Issue , 2007, Pages

  Omoigui, Sota ^a  

^a LA Pain Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; APIGENIN; BISPHOSPHONIC ACID DERIVATIVE; CAFFEIC ACID; CHLOROGENIC ACID; CHOLESTEROL; COMPACTIN; EPICATECHIN; ETIDRONIC ACID; FERULIC ACID; FLAVONOID; GALLOCATECHIN; HYDROCINNAMIC ACID; HYDROXYBENZOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LIGNAN; LUTEOLIN; MEVINOLIN; PAMIDRONIC ACID; PARA COUMARIC ACID; PELARGONIDIN; POLYPHENOL; PRAVASTATIN; QUINIC ACID; RISEDRONIC ACID; SIMVASTATIN; SINAPIC ACID; STILBENE DERIVATIVE; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; CANCER; CHOLESTEROL SYNTHESIS; CORONARY ARTERY DISEASE; DEMENTIA; DRUG MECHANISM; DRUG TARGETING; FRUIT; GERIATRIC DISORDER; HUMAN; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VEGETABLE;

EID: 34047193690     PISSN: 17424933     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4933-4-1     Document Type: Article

References (181)

1. Huang H Patel DD Manton KG The immune system in aging: Roles of cytokines, T cells and NK cells Front Biosci 10 192-215 2005 Jan 1; Print 2005 Jan 1 15574362
2. Hackam DG Anand SS Emerging risk factors for atherosclerotic vascular disease: A critical review of the evidence JAMA 290 7 932-40 2003 Aug 20 10.1001/jama.290.7.932 12928471
3. Ross R Atherosclerosis an inflammatory disease N Engl J Med 1999 340 115-26 10.1056/NEJM199901143400207 9887164
4. Libby P Ridker PM Maser A Inflammation and atherosclerosis Circulation 2002 105 1135-43 10.1161/hc0902.104353 11877368
5. Ross R Cell biology of atherosclerosis Annu Rev Physiol 1995 57 791-804 10.1146/annurev.ph.57.030195.004043 7778883
6. Tabas I Free cholesterol-induced cytotoxicity. A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions Trends Cardiovasc Med 1997 7 256-263 10.1016/ S1050-1738(97)00086-8
7. Kockx MM Apoptosis in the atherosclerotic plaque: Quantitative and qualitative aspects Arterioscler Thromb Vasc Biol 1998 18 1519-1522 9763521
8. Mitchinson MJ Hardwick SJ Bennett MR Cell death in atherosclerotic plaques Curr Opin Lipidol 1996 7 324-329 8937524
9. Bonetti PO Lerman LO Napoli C Lerman A Statin effects beyond lipid lowering - are they clinically relevant? Eur Heart J 2003 24 3 225-48 10.1016/S0195-668X(02)00419-0 12590901
10. Davignon J Mabile L Mechanisms of action of statins and their pleiotropic effects [Article in French] Ann Endocrinol (Paris) 2001 62 1 Pt 2 101-12 11240412
11. McFarlane SI Muniyappa R Shin JJ Bahtiyar G Sowers JR Osteoporosis and cardiovascular disease: Brittle bones and boned arteries, is there a link? Endocrine 2004 23 1 1-10 10.1385/ENDO:23:1:01 15034190
12. Heinrich PC Castell JV Andus T Interleukin-6 and the acute phase response Biochem J 1990 265 621-636 1133681 1689567
13. Biasucci LM Vitelli A Liuzzo G Altamura S Caligiuri G Monaco C Rebuzzi AG Ciliberto G Maseri A Elevated levels of interleukin-6 in unstable angina Circulation 1996 94 874-877 8790019
14. Biasucci LM Liuzzo G Fantuzzi G Caligiuri G Rebuzzi Ag Ginnetti F Dinarello CA Maseri A Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increasing risk of in-hospital coronary events Circulation 1999 99 2079-2084 10217645
15. Szekanecz Z Shah MR Pearce WH Koch AE Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation Agents Actions 1994 42 159-162 10.1007/BF01983484 7879703
16. Ridker PM Rifai N Pfeifer M Sacks F Lepage S Braunwald E Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction Circulation 2000 101 2149-2153 10801754
17. Ridker PM Rifai N Stampfer MJ Hennekens CH Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 2000 101 1767-1772 10769275
18. Ma J Hennekens CH Ridker PM Stampfer MJ A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study J Am Coll Cardiol 1999 33 1347-1352 10.1016/S0735-1097(99)00007-8 10193737
19. Berk BC Weintraub WS Alexander RW Elevation of C-reactive protein in "active" coronary artery disease Am J Cardiol 1990 65 168-172 10.1016/0002-9149(90)90079-G 2296885
20. Ford ES Giles WH Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: Findings from National Health and Nutrition Examination Survey III J Clin Epidemiol 2000 53 95-102 10.1016/S0895-4356(99)00143-2 10693909
21. Morrow DA Ridker PM C-reactive protein, inflammation, and coronary risk Med Clin North Am 2000 84 149-161 10.1016/S0025-7125(05)70211-X 10685132
22. Ridker PM Rifai N Pfeifer MA Sacks F Braunwald E Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators Circulation 1999 100 230-235 10411845
23. Schaumberg DA Ridker PM Glynn RJ Christen WG Dana MR Hennekens CH High levels of plasma C-reactive protein and future risk of age-related cataract Ann Epidemiol 1999 9 166-171 10.1016/S1047-2797(98)00049-0 10192648
24. Ridker PM Cushman M Stampfer MJ Tracy RP Hennekens CH Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 1998 97 425-428 9490235
25. Cesari M Penninx BW Newman AB Kritchevsky SB Nicklas BJ Sutton-Tyrrell K Rubin SM Ding J Simonsick EM Harris TB Pahor M Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study Circulation 108 19 2317-22 2003 Nov 11 10.1161/ 01.CIR.0000097109.90783.FC 14568895
26. King MW Medical Biochemistry Course Guide, 2004 Cholesterol and Bile Metabolism Indiana University School of Medicine
27. Zhao L Hart S Cheng J Melenhorst JJ Bierie B Ernst M Stewart C Schaper F Heinrich PC Ullrich A Robinson GW Hennighausen L Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK J Biol Chem 279 42-44093 100 2004 Oct 15;. Epub 2004 Jul 30 10.1074/jbc.M313131200 15292206
28. Cesari M Penninx BW Newman AB Kritchevsky SB Nicklas BJ Sutton-Tyrrell K Tracy RP Rubin SM Harris TB Pahor M Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study) Am J Cardiol 92 5 522-8 2003 Sep 1 10.1016/ S0002-9149(03)00718-5 12943870
29. Yaffe K Lindquist K Penninx BW Simonsick EM Pahor M Kritchevsky S Launer L Kuller L Rubin S Harris T Inflammatory markers and cognition in well-functioning African-American and white elders Neurology 61 1 76-80 2003 Jul 8 12847160
30. Kurihara N Bertolini D Suda T Akiyama Y Roodman GD IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release J Immunol 1990 144 4226-4230 2341718
31. Tamura T Udagawa N Takahashi N Miyaura C Tanaka S Koishihara Y Ohsugi Y Kumaki K Taga T Kishimoto T Suda T Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6 Proc Natl Acad Sci USA 1993 90 11924-11928 48097 8265649 10.1073/pnas.90.24.11924
32. Manolagas SC Jilka RL Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis N Engl J Med 332 5 305-11 1995 Feb 2 10.1056/NEJM199502023320506 7816067
33. Yoshii T Magara S Miyai D Nishimura H Kuroki E Furudoi S Komori T Ohbayashi C Local levels of interleukin-1beta, -4, -6 and tumor necrosis factor alpha in an experimental model of murine osteomyelitis due to staphylococcus aureus Cytokine 19 2 59-65 2002 Jul 21 10.1006/ cyto.2002.1039 12182840
34. Meghji S Crean SJ Hill PA Sheikh M Nair SP Heron K Henderson B Mawer EB Harris M Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: Possible role in S. aureus-induced bone pathology Br J Rheumatol 1998 37 10 1095-101 10.1093/rheumatology/ 37.10.1095 9825749
35. Hotokezaka H Kitamura A Matsumoto S Hanazawa S Amano S Yamada T Internalization of Mycobacterium bovis Bacillus Calmette-Guerin into osteoblast-like MC3T3-E1 cells and bone resorptive responses of the cells against the infection Scand J Immunol 1998 47 5 453-8 10.1046/ j.1365-3083.1998.00318.x 9627129
36. Kiecolt-Glaser JK Preacher KJ MacCallum RC Atkinson C Malarkey WB Glaser R Chronic stress and age-related increases in the proinflammatory cytokine IL-6 Proc Natl Acad Sci USA 100 15 9090-5 2003 Jul 22; Epub 2003 Jul 2 166443 12840146 10.1073/pnas.1531903100
37. Lutgendorf SK Garand L Buckwalter KC Reimer TT Hong SY Lubaroff DM Life stress, mood disturbance, and elevated interleukin-6 in healthy older women J Gerontol A Biol Sci Med Sci 1999 54 9 M434-9 10536645
38. Heinrich PC Behrmann I Muller-Newen G Schaper F Graeve L Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway Biochem J 334 Pt 2 297-314 1998 Sep 1 1219691 9716487
39. Darnell JE Jr STATs and gene regulation Science 1997 277 5332 1630-1635 10.1126/science.277.5332.1630 9287210
40. Ogata A Nishimoto N Yoshizaki K Advances in interleukin-6 therapy Rinsho Byori 1999 47 4 321-6 10340005
41. Hirano T Nakajima K Hibi M Signaling mechanisms through gp130: A model of the cytokine system Cytokine Growth Factor Rev 1997 8 4 241-52 10.1016/S1359-6101(98)80005-1 9620640
42. Akira S IL-6-regulated transcription factors Int J Biochem Cell Biol 1997 29 12 1401-18 10.1016/S1357-2725(97)00063-0 9570135
43. Karin M The regulation of AP-1 activity by mitogen-activated protein kinases J Biol Chem 1995 270 16483-6 7622446
44. Sen R Baltimore D Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 1986 46 706-716 10.1016/ 0092-8674(86)90346-6
45. Fujita T Nolan GP Ghosh S Baltimore D Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κβ Genes Dev 1992 6 775-787 1577272
46. Zhong H SuYang H Erdjument-Bromage H Tempst P Ghosh S The transcriptional activity of NF-κβ is regulated by the I-κβ-associated PKAc subunit through a cyclic AMP-independent mechanism Cell 1997 89 413-424 10.1016/S0092-8674(00)80222-6 9150141
47. Verma I Stevenson JK Schwarz EM Van Antwerp D Miyamoto S Rel/ NFκβ/Iκβ family: Intimate tales of association and dissociation Genes Dev 1995 9 2723-2735 7590248
48. Chen Z Parent L Maniatis T Site-specific phosphorylation of Iκβα by a novel ubiquitination-dependent pathway Cell 1996 84 853-862 10.1016/S0092-8674(00)81064-8 8601309
49. Baeuerle PA Henkel T Function and activation of NF-κB 1995 Rel/NF T 1996 Site-specific phosphorylation of Iin vitro cell mediated immune assay predicts in vivo response J Rheumatol 1994 18 1130-1133
50. Verma I Stevenson JK Schwarz EM Van Antwerp D Miyamoto S Rel/ NFκβ/Iκβ family: Intimate tales of association and dissociation Genes Dev 1995 9 2723-2735 7590248
51. Rothwarf DM Zandi E Natoli G Karin M IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex Nature 395 6699 297-300 1998 Sep 17 9751060
52. Alkalay I Yaron A Hatzubai A Orian A Ciechanover A Ben-Neriah Y Stimulation-dependent Iκβα phosphorylation marks the NFκβ inhibitor for degradation via the ubiquitin-proteasome pathway Proc Natl Acad Sci USA 1995 92 10599-10603 40659 7479848 10.1073/ pnas.92.23.10599
53. Palombella VJ Rando OJ Goldberg AL Maniatis T The ubiquitin-proteasome pathway is required for processing the NF-κβ1 precursor protein and the activation of NF-κβ Cell 1994 78 773-785 10.1016/S0092-8674(94)90482-0 8087845
54. Baldwin AS The NFκB and IκB proteins: New discoveries and insights Annu Rev Immunol 1996 14 649-681 10.1146/ annurev.immunol.14.1.649 8717528
55. Adcock IM Lane SJ Brown CR Lee TH Barnes PJ Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma J Exp Med 1995 182 1951-1958 10.1084/jem.182.6.1951 7500041
56. McKay LI Cidlowski JA Cross-Talk between Nuclear Factor-κB and the Steroid Hormone Receptors: Mechanisms of Mutual Antagonism Molecular Endocrinology 1998 12 1 45-56 10.1210/me.12.1.45 9440809
57. Zhong H SuYang H Erdjument-Bromage H Tempst P Ghosh S The transcriptional activity of NF-κβ is regulated by the I-κβ-associated PKAc subunit through a cyclic AMP-independent mechanism Cell 1997 89 413-424 10.1016/S0092-8674(00)80222-6 9150141
58. Karin M Ben-Neriah Y Phosphorylation meets ubiquitination: The control of NF-kB activity Annu Rev Immunol 2000 18 621-63 10.1146/ annurev.immunol.18.1.621 10837071
59. Vanden Berghe W Vermeulen L Delerive P De Bosscher K Staels B Haegeman G A paradigm for gene regulation: Inflammation, NF-kappaB and PPAR Adv Exp Med Biol 2003 544 181-96 14713228
60. Han Y Runge MS Brasier AR Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors Circ Res 84 6 695-703 1999 Apr 2 10189357
61. Cabrero A Laguna JC Vazquez M Peroxisome proliferator-activated receptors and the control of inflammation Curr Drug Targets Inflamm Allergy 2002 1 3 243-8 10.2174/1568010023344616 14561188
62. Neve BP Fruchart JC Staels B Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis Biochem Pharmacol 60 8 1245-50 2000 Oct 15 10.1016/S0006-2952(00)00430-5 11007963
63. Leung KC Regulation of cytokine receptor signaling by nuclear hormone receptors: A new paradigm for receptor interaction DNA Cell Biol 2004 23 8 463-74 10.1089/1044549041562285 15307949
64. Das UN Statins and the prevention of dementia CMAJ 165 7 908-909 OCT. 2, 2001 81500 11599331
65. Takai Y Sasaki T Matozaki T Small GTP-binding proteins Physiol Rev 2001 81 1 153-208 11152757
66. Wennerberg K Rossman KL Der CJ The Ras superfamily at a glance J Cell Sci 118 Pt 5 843-6 2005 Mar 1 15731001
67. Magee T Marshall C New insights into the interaction of Ras with the plasma membrane Cell 1999 98 9-12 10.1016/S0092-8674(00)80601-7 10412976
68. Dechend R Müller D Park JK Fiebeler A Haller H Luft FC Statins and angiotensin II-induced vascular injury Nephrol Dial Transplant 2002 17 349-353 10.1093/ndt/17.3.349 11865073
69. Beaupre DM Kurzrock R RAS and leukemia: From basic mechanisms to gene-directed therapy J Clin Oncol 1999 17 3 1071-9 10071302
70. Sano M Fukuda K Kodama H Takahashi T Kato T Hakuno D Sato T Manabe T Tahara S Ogawa S Autocrine/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation Biochem Biophys Res Commun 269 3 798-802 2000 Mar 24 10.1006/bbrc.2000.2364 10720495
71. Faruqi TR Gomez D Bustelo XR Bar-Sagi D Reich NC Rac1 mediates STAT3 activation by autocrine IL-6 Proc Natl Acad Sci USA 98 16 9014-9 2001 Jul 31; Epub 2001 Jul 24 55365 11470914 10.1073/pnas.161281298
72. Aznar S Valeron PF del Rincon SV Perez LF Perona R Lacal JC Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation Mol Biol Cell 2001 12 10 3282-94 60173 11598209
73. Lubbert M Oster W Knopf HP McCormick F Mertelsmann R Herrmann F N-RAS gene activation in acute myeloid leukemia: Association with expression of interleukin-6 Leukemia 1993 7 12 1948-54 8255093
74. Pelletier S Duhamel F Coulombe P Popoff MR Meloche S Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors Mol Cell Biol 2003 23 4 1316-33 141129 12556491 10.1128/ MCB.23.4.1316-1333.2003
75. Khwaja A O'Connolly J Hendry BM Prenylation inhibitors in renal disease Lancet 2000 355 741-744 10.1016/S0140-6736(99)08347-6 10703816
76. Ikeda U Shimpo M Ohki R Inaba H Takahashi M Yamamoto K Shimada K Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells Hypertension 2000 36 325-329 10988259
77. Bergstrom JD Bostedor RG Masarachia PJ Reszka AA Rodan G Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase Arch Biochem Biophys 373 1 231-41 2000 Jan 1 10.1006/abbi.1999.1502 10620343
78. Rogers MJ New insights into the molecular mechanisms of action of bisphosphonates Curr Pharm Des 2003 9 32 2643-58 10.2174/ 1381612033453640 14529538
79. Manzoni M Rollini M Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs Appl Microbiol Biotechnol 2002 58 5 555-64 Epub 2002 Feb 14 10.1007/s00253-002-0932-9 11956737
80. Manach C Scalbert A Morand C Remesy C Jimenez L Polyphenols: Food sources and bioavailability Am J Clin Nutr 2004 79 5 727-47 15113710
81. Funakoshi Y Ichiki T Ito K Takeshita A Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells Hypertension 1999 34 1 118-25 10406834
82. Keidar S Heinrich R Kaplan M Hayek T Aviram M Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: A possible role for interleukin-6 Arterioscler Thromb Vasc Biol 2001 21 9 1464-9 11557673
83. Klouche M Rose-John S Schmiedt W Bhakdi S Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation Circulation 101 15 1799-805 2000 Apr 18 10769280
84. Klouche M Bhakdi S Hemmes M Rose-John S Novel path to activation of vascular smooth muscle cells: Up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor J Immunol 163 8 4583-9 1999 Oct 15 10510402
85. Nabata T Morimoto S Koh E Shiraishi T Ogihara T Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells Biochem Int 1990 20 3 445-53 2346497
86. Seino Y Ikeda U Ikeda M Yamamoto K Misawa Y Hasegawa T Kano S Shimada K Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions Cytokine 1994 6 1 87-91 10.1016/1043-4666(94)90013-2 8003639
87. Tokunou T Ichiki T Takeda K Funakoshi Y Iino N Shimokawa H Egashira K Takeshita A Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 2001 21 11 1759-63 11701462
88. Williams N Bertoncello I Jackson H Arnold J Kavnoudias H The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production Ciba Found Symp 1992 167 160-170 discussion 170-173 1425011
89. Oleksowicz L Mrowiec Z Zuckerman D Isaacs R Dutcher J Puszkin E Platelet activation induced by interleukin-6: Evidence for a mechanism involving arachidonic acid metabolism Thromb Haemost 1994 72 302-308 7831669
90. Burstein SA Effects of interleukin 6 on megakaryocytes and on canine platelet function Stem Cells 1994 12 386-393 7951005
91. Watanabe S Mu W Kahn A Jing N Li JH Lan HY Nakagawa T Ohashi R Johnson RJ Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells Am J Nephrol 2004 24 4 387-92 Epub 2004 Jul 9 10.1159/000079706 15256805
92. Okopien B Hyper M Kowalski J Belowski D Madej A Zielinski M Tokarz D Kalina Z Herman ZS A new immunological marker of atherosclerotic injury of arterial wall Res Commun Mol Pathol Pharmacol 2001 109 3-4 241-8 11758653
93. Nawawi H Osman NS Annuar R Khalid BA Yusoff K Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin Atherosclerosis 2003 169 2 283-91 10.1016/ S0021-9150(03)00193-X 12921980
94. Martin TJ Grill V Experimental and clinical pharmacology: bisphosphonates-mechanisms of action Aust Prescriber 2000 23 6 130-2
95. Wuster C Heilmann P [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate] Fortschr Med 115 29 37-42 1997 Oct 20 9445833
96. Rendina D Postiglione L Vuotto P Numis FG Di Domenico G Viceconti R Mossetti G Nunziata V Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone Clin Exp Rheumatol 2002 20 3 359-64 12102472
97. Olmos JM De Vega T Perera L Riancho JA Amado JA Gonzalez-Macias J Etidronate inhibits the production of IL-6 by osteoblast-like cells Methods Find Exp Clin Pharmacol 1999 21 8 519-22 10.1358/ mf.1999.21.8.794832 10599049
98. Giuliani N Pedrazzoni M Passeri G Girasole G Bisphosphonates inhibit IL-6 production by human osteoblast-like cells Scand J Rheumatol 1998 27 1 38-41 10.1080/030097498441155 9506876
99. Vitte C Fleisch H Guenther HL Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption Endocrinology 1996 137 6 2324-33 10.1210/en.137.6.2324 8641182
100. Plotkin LI Weinstein RS Parfitt AM Roberson PK Manolagas SC Bellido T Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin J Clin Invest 1999 104 10 1363-74 409837 10562298
101. Abildgaard N Rungby J Glerup H Brixen K Kassem M Brincker H Heickendorff L Eriksen EF Nielsen JL Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma Eur J Haematol 1998 61 2 128-34 9714526
102. Chen X Garner SC Quarles LD Anderson JJ Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation J Nutr Biochem 2003 14 6 342-9 10.1016/ S0955-2863(03)00056-1 12873716
103. Kim BH Chung EY Ryu JC Jung SH Min KR Kim Y Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response Arch Pharm Res 2003 26 4 306-11 12735689
104. Suh KS Koh G Park CY Woo JT Kim SW Kim JW Park IK Kim YS Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells Phytochemistry 2003 63 2 209-15 10.1016/S0031-9422(03)00101-8 12711143
105. Borsellino N Bonavida B Ciliberto G Toniatti C Travali S D'Alessandro N Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity Cancer 85 1 134-44 1999 Jan 1 10.1002/ (SICI)1097-0142(19990101)85:1<134::AID-CNCR19>3.0.CO;2-C 9921985
106. Jones TH Justice SK Price A Suppression of tyrosine kinase activity inhibits [3H]thymidine uptake in cultured human pituitary tumor cells J Clin Endocrinol Metab 1997 82 7 2143-7 10.1210/jc.82.7.2143 9215285
107. Geng Y Zhang B Lotz M Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes J Immunol 151 12 6692-700 1993 Dec 15 8258685
108. Lin JK Liang YC Lin-Shiau SY Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade Biochem Pharmacol 1999 58 911-5 10.1016/S0006-2952(99)00112-4 10509743
109. Pan MH Lin-Shiau SY Ho CT Lin JH Lin JK Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3.-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages Biochem Pharmacol 2000 59 357-67 10.1016/S0006-2952(99)00335-4 10644043
110. Wang ZY Huang MT Lou YR Xie JG Reuhl KR Newmark HL Ho CT Yang CS Conney AH Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice Cancer Res 1994 54 3428-35 8012962
111. Yang F Oz HS Barve S de Villiers WJ McClain CJ Varilek GW The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6 Mol Pharmacol 2001 60 3 528-33 11502884
112. Aneja R Hake P Denenberg A Burroughs T Wong H Zingarelli B Epigallocatechin, a Green Tea Polyphenol, Attenuates Myocardial Ischemia Reperfusion Injury in Rats Molecular Medicine 2004 10 1-6 1431348 15502876
113. Dona M Dell'Aica I Calabrese F Benelli R Morini M Albini A Garbisa S Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis J Immunol 2003 170 4335-41 12682270
114. Levites Y Amit T Youdim MB Mandel S Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action J Biol Chem 2002 277 30574-80 10.1074/jbc.M202832200 12058035
115. Levites Y Youdim MB Maor G Mandel S Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures Biochem Pharmacol 2002 63 21-9 10.1016/S0006-2952(01)00813-9 11754870
116. Ahmad N Feyes DK Nieminen AL Agarwal R Mukhtar H Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells J Natl Cancer Inst 1997 89 1881-6 10.1093/jnci/89.24.1881 9414176
117. Tedeschi E Suzuki H Menegazzi M Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition Ann N Y Acad Sci 2002 973 435-7 12485906
118. Watson JL Ansari S Cameron H Wang A Akhtar M McKay DM Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4 Am J Physiol Gastrointest Liver Physiol 2004 287 5 G954-61 Epub 2004 Jul 1 10.1152/ ajpgi.00302.2003 15231486
119. Abbate R Gori AM Martini F Brunelli T Filippini M Francalanci I Paniccia R Prisco D Gensini GF Neri Serneri GG n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production Prostaglandins Leukot Essent Fatty Acids 1996 54 6 439-44 10.1016/S0952-3278(96)90028-9 8888356
120. Khalfoun B Thibault F Watier H Bardos P Lebranchu Y Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6 Adv Exp Med Biol 1997 400B 589-97 9547608
121. Taylor AJ Kent SM Flaherty PJ Coyle LC Markwood TT Vernalis MN ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness Circulation 106 16 2055-60 2002 Oct 15 10.1161/ 01.CIR.0000034508.55617.65 12379573
122. Kastelein JJ de Groot E Sankatsing R Atherosclerosis measured by B-mode ultrasonography: Effect of statin therapy on disease progression Am J Med 116 Suppl 6A 31S-36S 2004 Mar 22 15050190
123. Koshiyama H Nakamura Y Tanaka S Minamikawa J Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes J Clin Endocrinol Metab 2000 85 8 2793-2796 10.1210/jc.85.8.2793 10946883
124. Daoud AS Frank AS Jarmolych J Fritz KE The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on necrosis of atherosclerotic lesions Atherosclerosis 1987 67 1 41-8 10.1016/0021-9150(87)90263-2 3118892
125. Maziere C Conte MA Maziere JC Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein Free Radic Biol Med 31 11 1334-40 2001 Dec 1 10.1016/S0891-5849(01)00649-9 11728804
126. Lee CS Kwon SJ Na SY Lim SP Lee JH Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits J Korean Med Sci 2004 19 5 656-61 15483339
127. Funakoshi Y Ichiki T Ito K Takeshita A Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells Hypertension 1999 34 1 118-25 10406834
128. Ruetten H Thiemermann C Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone J Physiol Pharmacol 1997 48 4 675-88 9444616
129. Browatzki M Schmidt J Kubler W Kranzhofer R Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells Basic Res Cardiol 2000 95 2 98-105 10.1007/s003950050170 10826501
130. Stephens JW Hurel SJ Cooper JA Acharya J Miller GJ Humphries SE A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus Mol Genet Metab 2004 82 2 180-6 10.1016/j.ymgme.2004.04.001 15172007
131. Okamoto T Yamagishi S Inagaki Y Amano S Takeuchi M Kikuchi S Ohno S Yoshimura A Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro Biochem Biophys Res Commun 297 2 419-24 2002 Sep 20 10.1016/S0006-291X(02)02218-0 12237136
132. Yamagishi S Abe R Inagaki Y Nakamura K Sugawara H Inokuma D Nakamura H Shimizu T Takeuchi M Yoshimura A Bucala R Shimizu H Imaizumi T Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling Am J Pathol 2004 165 6 1865-74 1618714 15579431
133. Jude EB Selby PL Burgess J Lilleystone P Mawer EB Page SR Donohoe M Foster AV Edmonds ME Boulton AJ Bisphosphonates in the treatment of Charcot neuroarthropathy: A double-blind randomised controlled trial Diabetologia 2001 44 11 2032-7 10.1007/s001250100008 11719835
134. A coronary primary prevention study of Scottish men aged 45-64 years: trial design. The West of Scotland Coronary Prevention Study Group J Clin Epidemiol 1992 45 8 849-60 10.1016/0895-4356(92)90068-X 1624967
135. Wong V Stavar L Szeto L Uffelman K Wang CH Fantus IG Lewis GF Atorvastatin induces insulin sensitization in Zucker lean and fatty rats Atherosclerosis 2006 184 2 348-55 Epub 2005 Jul 5 10.1016/ j.atherosclerosis.2005.05.009 15998521
136. Suzuki M Kakuta H Takahashi A Shimano H Tada-Iida K Yokoo T Kihara R Yamada N Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice J Atheroscler Thromb 2005 12 2 77-84 15942117
137. Bhathena J Sam Velasquez T Manuel Beneficial role of dietary phytoestrogens in obesity and diabetes American Journal of Clinical Nutrition 2002 76 6 1191-1201 12450882
138. Jayagopal V Albertazzi P Kilpatrick ES Howarth EM Jennings PE Hepburn DA Atkin SL Beneficial effects of soy phytoestrogen intake in postmenopausal women with Type 2 diabetes Diabetes Care 2002 25 1709-1714 10.2337/diacare.25.10.1709 12351466
139. Bhathena SJ Velasquez MT Beneficial role of dietary phytoestrogens in obesity and diabetes Am J Clin Nutr 2002 76 1191-1201 12450882
140. Orsolya Mezei Banz J William Steger W Richard Peluso R Michael Winters A Todd Shay Neil Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells J Nutr 2003 133 1238-1243 12730403
141. McCarty MF Potential utility of natural polyphenols for reversing fat-induced insulin resistance Med Hypotheses 2005 64 3 628-35 10.1016/ j.mehy.2003.11.042 15617879
142. Shimura T Miura T Usami M Ishihara E Tanigawa K Ishida H Seino Y Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM) Biol Pharm Bull 1997 20 5 507-10 9178930
143. Omoigui S The Biochemical Origin of Pain: How a new law and new drugs have led to a medical breakthrough in the treatment of Persistent pain Hawthorne, California. State-of-the-Art Technologies Publishers 2004 15209987
144. Kotake S Sato K Kim KJ Takahashi N Udagawa N Nakamura I Yamaguchi A Kishimoto T Suda T Kashiwazaki S Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids form rheumatoid arthritis patients are responsible for osteoclast-like cell formation J Bone Miner Res 1996 11 88-95 8770701
145. Houssiau F Devoglaer JP Van Damme J Nagant de Deuxchaisnes C Van Snick J Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides Arthritis Rheum 1988 31 784-788 10.1002/art.1780310614 3260102
146. Veldman PH Reynen HM Arntz IE Goris RJ Signs and symptoms of reflex sympathetic dystrophy: Prospective study of 829 patients Lancet 342 8878 1012-6 1993 Oct 23 10.1016/0140-6736(93)92877-V 8105263
147. Manolagas SC Jilka RL Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis N Engl J Med 332 5 305-11 1995 Feb 2 10.1056/NEJM199502023320506 7816067
148. Roodman GD Osteoclast function in Paget's disease and multiple myeloma Bone 1995 17 57S-61S 10.1016/8756-3282(95)00179-H 8579899
149. Ravaud P Thepot C Auleley GR Amor B Imaging of multiple myeloma Ann Med Interne [Paris] 1996 147 370-5 9137684
150. Teoh G Anderson KC Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma Hematol Oncol Clin North Am 1997 11 27-42 10.1016/S0889-8588(05)70413-5 9081202
151. Teoh G Anderson KC Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma Hematol Oncol Clin North Am 1997 11 27-42 10.1016/S0889-8588(05)70413-5 9081202
152. SS Tabibzadeh U Santhanam PB Sehgal LT May Cytokine-induced production of IFN-β2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17β J Immunol 1989 142 3134-3139 2651521
153. Kania DM Binkley N Checovich M Havighurst T Schilling M Ershler WB Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density J Am Geriat Soc 1995 43 236-239 7884109
154. Ralston SH Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced Cytokine expression in post-menopausal osteoporosis J Bone Miner Res 1994 9 883-890 8079663
155. Daynes RA Araneo BA Ershler WB Maloney C Li GZ Ryu SY Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative J Immunol 1993 150 5219-5230 8515056
156. Pacifici R Brown C Puscheck E Friedrich E Slatopolsky E Maggio D McCracken R Avioli LV Effect of surgical menopause and estrogen replacement on Cytokine release from human blood mononuclear cells Proc Natl Acad Sci USA 1991 88 5134-5138 51826 2052592 10.1073/pnas.88.12.5134
157. Pioli G Basini G Pedtazzoni M Musetti G Ulietti V Bresciani D Villa P Bacchi A Hughes D Russel M Passeri M Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophorectomy Clin Sci 1992 83 503-507 1330414
158. Girasole G Jilka RL Passeri F Boswell S Boder G Williams DC Manologas SC 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens J Clin Invest 1992 89 883-891 442934 1541679
159. Girasole G Jilka RL Passeri F Boswell S Boder G Williams DC Manologas SC 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens) J Clin Invest 1992 89 883-891 442934 1541679
160. Jilka RL Hangoc C Girasole G Passeri G Williams DC Abrams JS Boyce B Broxmeyer H Manolagas SC Increased osteoclast development after estrogen loss: Mediation by interleukin-6 Science 1992 257 88-91 10.1126/ science.1621100 1621100
161. Omoigui S The Biochemical Origin of Pain: How a new law and new drugs have led to a medical breakthrough in the treatment of Persistent pain Hawthorne, California. State-of-the-Art Technologies Publishers 2004 15209987
162. Nakatsuka K Development of bisphosphonates Nippon Rinsho 2003 61 2 219-25 12638211
163. Rodan GA Reszka AA Bisphosphonate mechanism of action Curr Mol Med 2002 2 6 571-7 10.2174/1566524023362104 12243249
164. Reszka AA Rodan GA Bisphosphonate mechanism of action Curr Rheumatol Rep 2003 5 1 65-74 12590887
165. Bauer DC HMG CoA reductase inhibitors and the skeleton: A comprehensive review Osteoporos Int 2003 14 4 273-82 Epub 2003 May 08 10.1007/ s00198-002-1323-x 12736772
166. Funkhouser HL Adera T Adler RA Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density J Clin Densitom 2002 5 2 151-8 10.1385/ JCD:5:2:151 12110758
167. Pasco JA Kotowicz MA Henry MJ Sanders KM Nicholson GC Geelong Osteoporosis Study Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study Arch Intern Med 162 5 537-40 2002 Mar 11 10.1001/archinte.162.5.537 11871921
168. Staal A Frith JC French MH Swartz J Gungor T Harrity TW Tamasi J Rogers MJ Feyen JH The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity J Bone Miner Res 2003 18 1 88-96 10.1359/jbmr.2003.18.1.88 12510809
169. Harkness LS Fiedler K Sehgal AR Oravec D Lerner E Decreased bone resorption with soy isoflavone supplementation in postmenopausal women J Womens Health (Larchmt) 2004 13 9 1000-7 15665657
170. Cotter A Cashman KD Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy Nutr Rev 2003 61 10 346-51 10.1301/nr.2003.oct.346-351 14604267
171. Sun D Krishnan A Zaman K Lawrence R Bhattacharya A Fernandes G Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice J Bone Miner Res 2003 18 7 1206-16 10.1359/ jbmr.2003.18.7.1206 12854830
172. Caruso C Lio D Cavallone L Franceschi C Aging, longevity, inflammation, and cancer Ann N Y Acad Sci 2004 1028 1-13 10.1196/annals.1322.001 15915584
173. Wu KD Orme LM Shaughnessy J Jr Jacobson J Barlogie B Moore MA Telomerase and telomere length in multiple myeloma: Correlations with disease heterogeneity, cytogenetic status, and overall survival Blood 101 12 4982-9 2003 Jun 15; Epub 2003 Feb 27 10.1182/blood-2002-11-3451 12609839
174. Kiecolt-Glaser JK Preacher KJ MacCallum RC Atkinson C Malarkey WB Glaser R Chronic stress and age-related increases in the proinflammatory cytokine IL-6 Proc Natl Acad Sci USA 100 15 9090-5 2003 Jul 22; Epub 2003 Jul 02 166443 12840146 10.1073/pnas.1531903100
175. Urbanski A Schwarz T Neuner P Krutmann J Kirnbauer R Kock A Luger TA Ultraviolet light induces increased circulating interleukin-6 in humans J Invest Dermatol 1990 94 6 808-11 10.1111/1523-1747.ep12874666 2355183
176. Xia J Song X Bi Z Chu W Wan Y UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro Int J Mol Med 2005 16 5 943-50 16211268
177. Seddon JM George S Rosner B Rifai N Progression of age-related macular degeneration: Prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers Arch Ophthalmol 2005 123 6 774-82 10.1001/archopht.123.6.774 15955978
178. Fishman D Faulds G Jeffery R Mohamed-Ali V Yudkin JS Humphries S Woo P The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 1998 102 1369-1376 508984 9769329
179. Linker-Israeli M DJ Wallace JL Prehn R Nand L Li JR Klinenberg A greater variability in the 3′ flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE) Autoimmunity 1996 23 199-209 8879455
180. Murray R F McGuigan S Grant D Reid S Ralston Polymorphisms of the interleukin-6 gene are associated with bone mineral density Bone 1997 21 89-92 10.1016/S8756-3282(97)00081-1 9213013
181. Dubey VS Mevalonate-independent pathway of isoprenoids synthesis: A potential target in some human pathogens Current science 83 6 685-687 25 September 2002